BBLG: Bone Biologics Corp Book Value of Business

Corporate emblem and logo of bonebiologics.com (BBLG)

Bone Biologics (BBLG) develops proteins for bone regeneration, leveraging high production scalability following certification. Protein synthesis automation allows for the optimization of research without hiring additional scientists, and the metric stands at 0.01. This daily price chart visualizes the asset's price action. Meanwhile, the business has yet to generate commercial sales, consuming capital to conduct clinical trials.

Bone Biologics Corp. (BBLG) - Company Book Value from 07/04/2022 to 10/27/2026

Financial and market metric breakdowns for Bone Biologics Corp (BBLG)

- price and consensus price forecast:
Price Chart Bone Biologics Inc|BBLG - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Bone Biologics Corp.|BBLG - Total Company Value
- book capitalization data:
Net Assets per Share Bone Biologics|BBLG - Company Book Value|Market Capitalization to Net Assets bonebiologics.com|BBLG - Company Total Assets
- debt and liquidity data:
Debt to Capital Bone Biologics|BBLG - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Bone Biologics Corp.|BBLG - Company Aggregate Debts|Debts to Net Assets Bone Biologics Corp.
Summary company analytics:BBLG - Bone Biologics Inc
Mass-produced product of Bone Biologics Corporation

Book value capitalization measures the net value of assets, representing the difference between total assets and all of the issuer's debt obligations. By analyzing the book value trend of Bone Biologics (BBLG), an investor can see the tangible foundation of Bone Biologics, which supports the development of bone materials and ensures stable demand for implants within orthopedic surgery standards.

Competitor analysis for Bone Biologics

BSX - Company Book Value|Book Capitalization EW (Edwards Lifesciences)|RMD (resmed.com) - Book Value of Business|PODD: Company Book Value|Book Valuation of Business ZBH|COO - Company Book Value|Net Asset Value Align Corp (ALGN)|GMED: Book Capitalization|Total Stockholders' Equity TransMedics Organ Care System TMDX|ATEC: Book Capitalization|AORT - Company Net Assets|DJO Global - Book Capitalization|Integra LifeSciences Inc. (IART) - Book Valuation of Business|ESTA (Establishment Labs) - Book Capitalization|Book Capitalization BBNX|Company Book Value IRADIMED (IRMD)|Company Book Value Embecta Corp (EMBC)|Book Capitalization TNDM|AXGN - Book Valuation of Business|Company Net Assets SI-BONE, Inc.|OFIX - Net Asset Value|Book Capitalization BVS|OrthoPediatrics (KIDS) - Total Stockholders' Equity|Book Capitalization Treace Medical (TMCI)|Accounting Capitalization Strata Medical (SRTA)|Carlsmed Inc (CARL) - Company Net Assets|Accounting Value of Company RXST (rxsight.com)|ClearPoint Neuro - Company Book Value|Company Net Assets Stereotaxis Inc STXS|STIM (NeuroStar) - Book Capitalization|SGHT - Total Stockholders' Equity|Book Capitalization Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Accounting Capitalization|NSPR: Book Capitalization|Book Valuation of Business Jin Medical International Ltd|Book Capitalization VANI (Vivani Medical, Inc.)|Company Net Assets xtantmedical.com (XTNT)|Book Capitalization NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Book Capitalization|MYO - Company Book Value|Envoy Medical Inc. (COCH) - Company Book Value|Company Net Assets Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Accounting Value of Company|Book Capitalization SINT (Sintx Technologies Inc)|Total Stockholders' Equity TNON|LFWD: Company Book Value|Book Value of Business autonomix.com AMIX|Company Net Assets IVF (INVO Bioscience, Inc.)|Book Capitalization Axonics, Inc AXNX|Book Capitalization BIOL (BIOLASE, Inc.)|DYNT: Book Valuation of Business|Company Book Value paragon28.com (FNA)|INVO (INVO Bioscience) - Net Asset Value